Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Aegerion Pharmaceuticals, Inc.
Biological Products Except Diagnostic Substances MA, United States
Nasdaq: AEGR
Company Description
Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It is engaged in the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases. The company's lead product, lomitapide, is a small molecule, oral therapy to treat severe lipid disorders for an orphan patient population. The company was founded by David I. Scheer and William H. Lewis on February 4, 2005 and is headquartered in Cambridge, MA.
Similar to: Cardium Therapeutics, Inc., Retrophin Inc, BioTime, Inc.
Featured Company
Nature Group Plc
St. Helier, JE, GB
NATURE GROUP is the market leader in handling Marpol and offshore waste, with more than 25 years’ collection and treatment experience.… Learn more →
Social Monitor
You may also be interested in:
BioTime, Inc.
Alameda, CA, US
BioTime, Inc. is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of… Learn more →
Retrophin Inc
New York, NY, US
Retrophin, Inc. (OTCQB: RTRX) New York-based, biotechnology company focused on discovering and developing treatments for rare and… Learn more →
Cardium Therapeutics, Inc.
San Diego, CA, US
Cardium Therapeutics, Inc. is an asset-based, health sciences and regenerative medicine company focused on acquiring and strategically… Learn more →